相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of Heterozygosity Proximal to the M6P/IGF2R Locus Is Predictive for the Presence of Disseminated Tumor Cells in the Bone Marrow of Ovarian Cancer Patients Before and After Chemotherapy
Jan Dominik Kuhlmann et al.
GENES CHROMOSOMES & CANCER (2011)
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
Pauline Wimberger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Monitoring of Loss of Heterozygosity in Serum Microsatellite DNA Among Patients with Gastrointestinal Stromal Tumors Indicates Tumor Recurrence
Tamina Rawnaq et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
Sian Rizzo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
PI(3)King Apart PTEN's Role in Cancer
Siyuan Zhang et al.
CLINICAL CANCER RESEARCH (2010)
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)
Andreas du Bois et al.
CANCER (2009)
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
Yanan Kuang et al.
CLINICAL CANCER RESEARCH (2009)
Management of Recurrent Ovarian Carcinoma: Current Status and Future Directions
Lainie P. Martin et al.
SEMINARS IN ONCOLOGY (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients:: Potential and technical improvements
Imke Mueller et al.
CLINICAL CHEMISTRY (2008)
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH (2007)
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer
Felix K. -H. Chun et al.
BJU INTERNATIONAL (2006)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
K Hamana et al.
BRITISH JOURNAL OF CANCER (2005)
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers
A Goel et al.
CANCER RESEARCH (2004)
Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA
MJ Wang et al.
CLINICAL CHEMISTRY (2004)
Loss of heterozygosity in serial plasma DNA samples during follow-up of women with breast cancer
Q Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer
S Makhija et al.
GYNECOLOGIC ONCOLOGY (2003)
Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997
MT Goodman et al.
CANCER (2003)
Persistence of tumor DNA in plasma of breast cancer patients after mastectomy
JM Silva et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients:: Follow-up study and prognostic significance
R Gonzalez et al.
ANNALS OF ONCOLOGY (2000)
The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
TL Wood et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2000)
分享论文
